Evidence map›Paper›PMID 41711831›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2026

Brazil accounts for nearly 90% of the leprosy cases in the Americas.

Ana Flávia Sobral de Medeiros, Aline Lidiane Batista, Sidnei Miyoshi Sakamoto, Diogo Manuel Lopes de Paiva Cavalcanti, Renata Ferreira Magalhães

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Ana Flávia Sobral de MedeirosUniversidade Federal Rural do Semi-Árido, Departamento Ciências da Saúde, Mossoró, RN, Brasil.ORCID http://orcid.org/0000-0001-5351-760X
Aline Lidiane BatistaUniversidade Federal Rural do Semi-Árido, Departamento Ciências da Saúde, Mossoró, RN, Brasil.ORCID http://orcid.org/0000-0003-2130-4807
Sidnei Miyoshi SakamotoUniversidade Federal Rural do Semi-Árido, Departamento Ciências da Saúde, Mossoró, RN, Brasil.ORCID http://orcid.org/0000-0003-4116-0388
Diogo Manuel Lopes de Paiva CavalcantiUniversidade Federal Rural do Semi-Árido, Departamento Ciências da Saúde, Mossoró, RN, Brasil.ORCID http://orcid.org/0000-0002-6395-7809
Renata Ferreira MagalhãesUniversidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Clínica Médica, Campinas, SP, Brasil.ORCID http://orcid.org/0000-0001-9170-932X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeprosy is endemic to Brazil. The Coronavirus disease 2019 (COVID-19) pandemic may have affected diagnosis and treatment.

methodsStudy in Mossoró-RN (2018-2023) analyzing epidemiological data, treatment abandonment, and COVID-19 co-infection.

resultsThe average weekly number of cases declined during the post-pandemic period. The dropout rate was higher during the acute phase. Male sex was associated with dropout (odds ratio [OR], 6.32; p = 0.013). Of the 57 patients tested for COVID-19, 21 tested positive, with no clinical aggravation.

conclusionsThe pandemic has affected leprosy control. Local strategies helped reduce the impact, and co-infection did not worsen the disease.

Indexed as

COVID-19LeprosyAdultBrazilCoinfectionFemaleHumansMaleMiddle Aged

Identifiers

PMID41711831
PMCPMC12904597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.